FMC Corporation (FMC)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
53.43
-0.10 (-0.19%)
At close: Jan 17, 2025, 3:59 PM
FMC Corporation Revenue Breakdown
Quarter | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fungicides Revenue | 84.80M | 74.50M | 70.40M | 88.80M | 55.50M | 72.30M | 101.00M | 136.60M | 75.30M | 63.30M | 108.70M | 77.10M | 63.40M | 94.50M | 90.50M | 71.00M | 59.40M | 61.80M | 83.30M | 81.40M | 61.30M | 58.20M | 70.50M |
Fungicides Revenue Growth | +13.83% | +5.82% | -20.72% | +60.00% | -23.24% | -28.42% | -26.06% | +81.41% | +18.96% | -41.77% | +40.99% | +21.61% | -32.91% | +4.42% | +27.46% | +19.53% | -3.88% | -25.81% | +2.33% | +32.79% | +5.33% | -17.45% | n/a |
Herbicides Revenue | 275.60M | 336.60M | 294.90M | 342.10M | 268.00M | 225.50M | 442.80M | 543.30M | 323.60M | 380.30M | 404.40M | 420.50M | 262.30M | 330.80M | 361.70M | 264.70M | 214.70M | 340.60M | 367.20M | 318.80M | 199.00M | 349.40M | 361.60M |
Herbicides Revenue Growth | -18.12% | +14.14% | -13.80% | +27.65% | +18.85% | -49.07% | -18.50% | +67.89% | -14.91% | -5.96% | -3.83% | +60.31% | -20.71% | -8.54% | +36.65% | +23.29% | -36.96% | -7.24% | +15.18% | +60.20% | -43.05% | -3.37% | n/a |
Insecticides Revenue | 647.90M | 569.10M | 501.30M | 651.40M | 582.40M | 658.90M | 746.70M | 810.50M | 872.30M | 897.10M | 766.70M | 798.90M | 792.30M | 741.80M | 687.00M | 689.70M | 746.80M | 679.90M | 720.40M | 710.20M | 649.70M | 710.30M | 703.40M |
Insecticides Revenue Growth | +13.85% | +13.52% | -23.04% | +11.85% | -11.61% | -11.76% | -7.87% | -7.08% | -2.76% | +17.01% | -4.03% | +0.83% | +6.81% | +7.98% | -0.39% | -7.65% | +9.84% | -5.62% | +1.44% | +9.31% | -8.53% | +0.98% | n/a |
Plant Health Revenue | 47.30M | 43.50M | 44.80M | 48.60M | 42.60M | 43.40M | 52.30M | 64.80M | 53.20M | 62.70M | 53.40M | 61.00M | 53.50M | 52.10M | 50.20M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Plant Health Revenue Growth | +8.74% | -2.90% | -7.82% | +14.08% | -1.84% | -17.02% | -19.29% | +21.80% | -15.15% | +17.42% | -12.46% | +14.02% | +2.69% | +3.78% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
Quarter | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Asia Pacific Revenue | 981.70M | 1.24B | 1.25B | 1.11B | 1.05B | 1.30B | 718.50M | 798.50M | 759.70M | 775.90M | 679.20M | 651.50M | 577.70M |
Asia Pacific Revenue Growth | -20.74% | -1.28% | +13.35% | +5.89% | -19.60% | +80.93% | -10.02% | +5.11% | -2.09% | +14.24% | +4.25% | +12.77% | n/a |
Brazil Revenue | 1.02B | 1.62B | 1.22B | 1.08B | 1.09B | 913.70M | 598.50M | 509.40M | 662.50M | 958.80M | 1.04B | 846.60M | 695.20M |
Brazil Revenue Growth | -37.25% | +32.40% | +13.01% | -0.98% | +19.74% | +52.66% | +17.49% | -23.11% | -30.90% | -8.08% | +23.21% | +21.78% | n/a |
Emea Revenue | 899.20M | 1.04B | 1.04B | 1.05B | 1.00B | 1.04B | 583.40M | 783.40M | 623.90M | 559.00M | 1.29B | 1.30B | 1.19B |
Emea Revenue Growth | -13.51% | -0.03% | -0.60% | +4.44% | -3.72% | +78.35% | -25.53% | +25.56% | +11.61% | -56.50% | -1.06% | +9.26% | n/a |
Latin America Revenue | 1.40B | 2.09B | 1.63B | 1.46B | 1.44B | 1.21B | 868.60M | 821.40M | 981.80M | 1.33B | 1.24B | 1.22B | 1.11B |
Latin America Revenue Growth | -32.90% | +27.84% | +12.15% | +1.03% | +18.94% | +39.55% | +5.75% | -16.34% | -26.43% | +7.21% | +2.22% | +9.75% | n/a |
North America Revenue | 1.20B | 1.44B | 1.12B | 1.03B | 1.12B | 1.18B | 708.10M | 879.10M | 911.10M | 1.37B | n/a | n/a | n/a |
North America Revenue Growth | -16.09% | +28.52% | +8.20% | -7.90% | -4.60% | +65.97% | -19.45% | -3.51% | -33.41% | n/a | n/a | n/a | n/a |
United States Revenue | 978.10M | 1.29B | 1.02B | 941.20M | 1.04B | 1.07B | 655.20M | 837.70M | 853.00M | 1.31B | n/a | n/a | n/a |
United States Revenue Growth | -24.11% | +26.59% | +8.17% | -9.86% | -2.80% | +63.95% | -21.79% | -1.79% | -35.07% | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
Quarter | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 29, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 159.20M | 164.90M | 164.00M | 171.50M | 171.30M | 205.60M | 185.90M | 212.50M | 179.40M | 194.80M | 188.50M | 195.10M | 183.50M | 161.00M | 174.50M | 181.60M | 187.70M | 171.00M | 189.40M | 223.80M | 188.30M | 196.90M | 183.90M | 202.60M | 207.60M | 211.40M | 200.40M | 231.60M | 150.90M | 126.40M | 109.70M | 156.10M | 117.80M | 129.10M | 126.50M | 147.00M | 137.00M | 156.00M | 297.90M |
Selling, General, and Administrative Revenue Growth | -3.46% | +0.55% | -4.37% | +0.12% | -16.68% | +10.60% | -12.52% | +18.45% | -7.91% | +3.34% | -3.38% | +6.32% | +13.98% | -7.74% | -3.91% | -3.25% | +9.77% | -9.71% | -15.37% | +18.85% | -4.37% | +7.07% | -9.23% | -2.41% | -1.80% | +5.49% | -13.47% | +53.48% | +19.38% | +15.22% | -29.72% | +32.51% | -8.75% | +2.06% | -13.95% | +7.30% | -12.18% | -47.63% | n/a |
Research and Development Revenue | 69.00M | 75.90M | 60.90M | 81.80M | 80.90M | 87.70M | 78.40M | 84.40M | 78.50M | 79.50M | 71.80M | 85.30M | 79.50M | 65.90M | 74.00M | 84.60M | 71.70M | 64.30M | 67.30M | 76.40M | 77.40M | 73.10M | 71.20M | 76.80M | 70.90M | 77.00M | 65.90M | 51.10M | 30.20M | 32.00M | 28.20M | 38.20M | 32.20M | 35.10M | 36.00M | 40.90M | 37.20M | 39.00M | 26.60M |
Research and Development Revenue Growth | -9.09% | +24.63% | -25.55% | +1.11% | -7.75% | +11.86% | -7.11% | +7.52% | -1.26% | +10.72% | -15.83% | +7.30% | +20.64% | -10.95% | -12.53% | +17.99% | +11.51% | -4.46% | -11.91% | -1.29% | +5.88% | +2.67% | -7.29% | +8.32% | -7.92% | +16.84% | +28.96% | +69.21% | -5.62% | +13.48% | -26.18% | +18.63% | -8.26% | -2.50% | -11.98% | +9.95% | -4.62% | +46.62% | n/a |